Your browser doesn't support javascript.
Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19.
Melero, Ignacio; Villalba-Esparza, María; Recalde-Zamacona, Borja; Jiménez-Sánchez, Daniel; Teijeira, Álvaro; Argueta, Alan; García-Tobar, Laura; Álvarez-Gigli, Laura; Sainz, Cristina; Garcia-Ros, David; Toledo, Estefanía; Abengozar-Muela, Marta; Fernández-Alonso, Mirian; Rodríguez-Mateos, Mariano; Reina, Gabriel; Carmona-Torre, Francisco; Quiroga, Jorge Augusto; Del Pozo, Jose L; Cross, Amy; López-Janeiro, Álvaro; Hardisson, David; Echeveste, José I; Lozano, Maria D; Ho, Ling-Pei; Klenerman, Paul; Issa, Fadi; Landecho, Manuel F; de Andrea, Carlos E.
  • Melero I; Division of Immunology and Immunotherapy, Centre for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Navarra Institute for Health Research, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
  • Villalba-Esparza M; Navarra Institute for Health Research, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Recalde-Zamacona B; Service of Pulmonary Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
  • Jiménez-Sánchez D; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Teijeira Á; Division of Immunology and Immunotherapy, Centre for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain; Navarra Institute for Health Research, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
  • Argueta A; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
  • García-Tobar L; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Álvarez-Gigli L; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Sainz C; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Garcia-Ros D; Department of Anatomy, Physiology and Pathology, University of Navarra, Pamplona, Spain.
  • Toledo E; Department of Preventive Medicine and Public Health, IdiSNA, University of Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición, Institute of Health Carlos III, Madrid, Spain.
  • Abengozar-Muela M; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
  • Fernández-Alonso M; Navarra Institute for Health Research, Pamplona, Spain; Department of Microbiology and Infectious Diseases, Clínica Universidad de Navarra, Pamplona, Spain.
  • Rodríguez-Mateos M; Department of Microbiology and Infectious Diseases, Clínica Universidad de Navarra, Pamplona, Spain.
  • Reina G; Navarra Institute for Health Research, Pamplona, Spain; Department of Microbiology and Infectious Diseases, Clínica Universidad de Navarra, Pamplona, Spain.
  • Carmona-Torre F; Navarra Institute for Health Research, Pamplona, Spain; Department of Microbiology and Infectious Diseases, Clínica Universidad de Navarra, Pamplona, Spain.
  • Quiroga JA; Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
  • Del Pozo JL; Navarra Institute for Health Research, Pamplona, Spain; Department of Microbiology and Infectious Diseases, Clínica Universidad de Navarra, Pamplona, Spain.
  • Cross A; Nuffield Department of Surgical Sciences, John Radcliffe Hospital, University of Oxford, Oxford, England.
  • López-Janeiro Á; Department of Pathology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
  • Hardisson D; Department of Pathology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
  • Echeveste JI; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain; Department of Anatomy, Physiology and Pathology, University of Navarra, Pamplona, Spain.
  • Lozano MD; Navarra Institute for Health Research, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain; Department of Anatomy, Physiology and Pathology, University of Navarra, Pamplona, Spain.
  • Ho LP; MRC Human Immunology Unit, University of Oxford, Oxford, England.
  • Klenerman P; Nuffield Department of Clinical Medicine, Peter Medawar Building for Pathogen Research, Oxford, England.
  • Issa F; Nuffield Department of Surgical Sciences, John Radcliffe Hospital, University of Oxford, Oxford, England.
  • Landecho MF; Department of Internal Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
  • de Andrea CE; Navarra Institute for Health Research, Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain; Department of Anatomy, Physiology and Pathology, University of Navarra, Pamplona, Spain. Electronic add
Chest ; 162(5): 1006-1016, 2022 Nov.
Article in English | MEDLINE | ID: covidwho-1944506
ABSTRACT

BACKGROUND:

Excessive inflammation is pathogenic in the pneumonitis associated with severe COVID-19. Neutrophils are among the most abundantly present leukocytes in the inflammatory infiltrates and may form neutrophil extracellular traps (NETs) under the local influence of cytokines. NETs constitute a defense mechanism against bacteria, but have also been shown to mediate tissue damage in a number of diseases. RESEARCH QUESTION Could NETs and their tissue-damaging properties inherent to neutrophil-associated functions play a role in the respiratory failure seen in patients with severe COVID-19, and how does this relate to the SARS-CoV-2 viral loads, IL-8 (CXCL8) chemokine expression, and cytotoxic T-lymphocyte infiltrates? STUDY DESIGN AND

METHODS:

Sixteen lung biopsy samples obtained immediately after death were analyzed methodically as exploratory and validation cohorts. NETs were analyzed quantitatively by multiplexed immunofluorescence and were correlated with local levels of IL-8 messenger RNA (mRNA) and the density of CD8+ T-cell infiltration. SARS-CoV-2 presence in tissue was quantified by reverse-transcriptase polymerase chain reaction and immunohistochemistry analysis.

RESULTS:

NETs were found in the lung interstitium and surrounding the bronchiolar epithelium with interindividual and spatial heterogeneity. NET density did not correlate with SARS-CoV-2 tissue viral load. NETs were associated with local IL-8 mRNA levels. NETs were also detected in pulmonary thrombi and in only one of eight liver tissues. NET focal presence correlated negatively with CD8+ T-cell infiltration in the lungs.

INTERPRETATION:

Abundant neutrophils undergoing NETosis are found in the lungs of patients with fatal COVID-19, but no correlation was found with viral loads. The strong association between NETs and IL-8 points to this chemokine as a potentially causative factor. The function of cytotoxic T-lymphocytes in the immune responses against SARS-CoV-2 may be interfered with by the presence of NETs.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Extracellular Traps / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Chest Year: 2022 Document Type: Article Affiliation country: J.chest.2022.06.007

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Extracellular Traps / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Chest Year: 2022 Document Type: Article Affiliation country: J.chest.2022.06.007